BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29518757)

  • 1. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.
    Lazaridou S; Dinas K; Tziomalos K
    Hormones (Athens); 2017 Oct; 16(4):373-380. PubMed ID: 29518757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.
    Capula C; Chiefari E; Vero A; Foti DP; Brunetti A; Vero R
    Diabetes Res Clin Pract; 2014 Aug; 105(2):223-30. PubMed ID: 24931701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study.
    Kazemi Jaliseh H; Ramezani Tehrani F; Behboudi-Gandevani S; Hosseinpanah F; Khalili D; Cheraghi L; Azizi F
    Fertil Steril; 2017 Dec; 108(6):1078-1084. PubMed ID: 29202960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
    Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
    Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Eur J Endocrinol; 2014 May; 170(5):727-39. PubMed ID: 24591551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome.
    Dargham SR; Shewehy AE; Dakroury Y; Kilpatrick ES; Atkin SL
    Sci Rep; 2018 Feb; 8(1):3619. PubMed ID: 29483674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.
    Long C; Feng H; Duan W; Chen X; Zhao Y; Lan Y; Yue R
    Front Endocrinol (Lausanne); 2022; 13():980405. PubMed ID: 36120432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.
    Ryu KJ; Kim MS; Kim HK; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T; Park H
    Fertil Steril; 2021 Jun; 115(6):1569-1575. PubMed ID: 33509630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome.
    Pirotta S; Joham A; Grieger JA; Tay CT; Bahri-Khomami M; Lujan M; Lim SS; Moran LJ
    Semin Reprod Med; 2020 Nov; 38(6):342-351. PubMed ID: 33873233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: A longitudinal observational study.
    Choi YM; Hwang KR; Oh SH; Lee D; Chae SJ; Yoon SH; Kim JJ
    Clin Endocrinol (Oxf); 2021 May; 94(5):837-844. PubMed ID: 33440048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
    Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
    Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome--a management update.
    Costello MF
    Aust Fam Physician; 2005 Mar; 34(3):127-33. PubMed ID: 15799658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.
    Chantrapanichkul P; Indhavivadhana S; Wongwananuruk T; Techatraisak K; Dangrat C; Sa-Nga-Areekul N
    Arch Gynecol Obstet; 2020 Mar; 301(3):809-816. PubMed ID: 31927625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.
    Trakakis E; Basios G; Peppa M; Simeonidis G; Labos G; Creatsa M; Misailidou M; Boutati E; Vaggopoulos V; Panagopoulos P; Dimitriades G; Kassanos D
    Gynecol Endocrinol; 2012 Nov; 28(11):867-70. PubMed ID: 22571176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.
    Li HW; Lam KS; Tam S; Lee VC; Yeung TW; Cheung PT; Yeung WS; Ho PC; Ng EH
    Hum Reprod; 2015 Sep; 30(9):2178-83. PubMed ID: 26202923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.